Daniel Paul Regan, CCO at Intercept Pharma, holds 0.00 shares in Keryx Biopharma (Ticker: KERX), holds 1.26K shares in Intercept Pharma (Ticker: ICPT).

See the Hottest Stocks Based on Insider Trading >

Daniel Paul Regan
Intercept Pharma (ICPT)
CCO

Not Ranked

Daniel Paul Regan has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

Daniel Paul Regan does not currently own shares as a corporate insider.

A breakdown of Daniel Paul Regan's holdings

See the Top Stocks by Insiders

Insider Roles

Daniel Paul Regan does not currently hold a role as a corporate insider.

Roles that Daniel Paul Regan holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Intercept Pharma
(ICPT)

Rating:Informative Sell

Date:Jan 07, 2015 - Jan 07, 2016

Return:+13.70%

The most profitable trade made by Daniel Paul Regan

See the Latest Stocks Traded by Insiders

Daniel Paul Regan's Trading History

ICPT

Intercept Pharma

Feb 03, 2015

―

Uninformative Sell

1.98M

$24.02K

KERX

Keryx Biopharma

Dec 13, 2018

―

Uninformative Sell

―

$0.00

List of latest transactions for each holding click on a transaction to see Daniel Paul Regan's performance on stock

See All Insider Trading from Today

Daniel Paul Regan insider profile FAQ

What is the percentage of profitable transactions made by Daniel Paul Regan?

The percentage of profitable transactions made by Daniel Paul Regan is ―.

What is the average return per transaction made by Daniel Paul Regan?

The average return per transaction made by Daniel Paul Regan is ―.

What stocks does Daniel Paul Regan hold?

Daniel Paul Regan holds: ICPT, KERX stocks.

What was Daniel Paul Regan’s latest transaction?

Daniel Paul Regan latest transaction was an Uninformative Sell of ―.

What was Daniel Paul Regan's most profitable transaction?

Daniel Paul Regan’s most profitable transaction was an Informative Sell of ICPT stock on January 7, 2015. The return on the trade was 13.70%.

What is Daniel Paul Regan's role in Intercept Pharma?

Daniel Paul Regan's role in Intercept Pharma is CCO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Daniel Paul Regan Insider Profile

Daniel Paul Regan Intercept Pharma (ICPT)CCO